Gtl_Medical_Ph.No.10046_Medicine_Human Insulin Analogue Inj (Biosynthetic R-Dna Origin) Soluble Insulin Aspart 100 Iu/Ml.

STORES SOUTH CENTRAL RLY India has Released a tender for Gtl_Medical_Ph.No.10046_Medicine_Human Insulin Analogue Inj (Biosynthetic R-Dna Origin) Soluble Insulin Aspart 100 Iu/Ml. in Pharmaceuticals. The tender was released on May 20, 2025.

Country - India

Summary - Gtl_Medical_Ph.No.10046_Medicine_Human Insulin Analogue Inj (Biosynthetic R-Dna Origin) Soluble Insulin Aspart 100 Iu/Ml.

Deadline - Jun 23, 2025

MT reference number - 109215274

Product classification - Medicinal products for the alimentary tract and metabolism

Organization Details:

  Address - India

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 109215274

  Document Type - Tender Notices

Notice Details and Documents:

Description - notice_title: Gtl_Medical_Ph.No.10046_Medicine_Human Insulin Analogue Inj (Biosynthetic R-Dna Origin) Soluble Insulin Aspart 100 Iu/Ml.local title:: GTL_Medical_PH.No.10046_MEDICINE_HUMAN INSULIN ANALOGUE INJ (BIOSYNTHETIC r-DNA ORIGIN) SOLUBLE INSUL IN ASPART 100 IU/ML.

Mt Ref Id - 109215274

Deadline - Jun 23, 2025

Share

Similar Tenders :